96 related articles for article (PubMed ID: 9257329)
21. 6-[Fluorine-18]fluorodopamine pharmacokinetics and dosimetry in humans.
Goldstein DS; Coronado L; Kopin IJ
J Nucl Med; 1994 Jun; 35(6):964-73. PubMed ID: 8195883
[TBL] [Abstract][Full Text] [Related]
22. Dosimetry of copper-64-labeled monoclonal antibody 1A3 as determined by PET imaging of the torso.
Cutler PD; Schwarz SW; Anderson CJ; Connett JM; Welch MJ; Philpott GW; Siegel BA
J Nucl Med; 1995 Dec; 36(12):2363-71. PubMed ID: 8523133
[TBL] [Abstract][Full Text] [Related]
23. Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.
Antenor-Dorsey JA; Markham J; Moerlein SM; Videen TO; Perlmutter JS
Nucl Med Biol; 2008 Apr; 35(3):335-41. PubMed ID: 18355689
[TBL] [Abstract][Full Text] [Related]
24. Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates.
Bélanger MJ; Krause SM; Ryan C; Sanabria-Bohorquez S; Li W; Hamill TG; Burns HD
Nucl Med Commun; 2008 Oct; 29(10):915-9. PubMed ID: 18769310
[TBL] [Abstract][Full Text] [Related]
25. Human Biodistribution and Radiation Dosimetry of S-11C-Methyl-L-Cysteine Using Whole-Body PET.
Yao B; Tang C; Tang G; Hu K; Liang X; Shi X; Nie D; Tang X; Yue D
Clin Nucl Med; 2015 Oct; 40(10):e470-4. PubMed ID: 25742235
[TBL] [Abstract][Full Text] [Related]
26. Radiation absorbed dose estimates for positron emission tomography (PET): K-38, Rb-81, Rb-82, and Cs-130.
Kearfott KJ
J Nucl Med; 1982 Dec; 23(12):1128-32. PubMed ID: 6982966
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.
DeGrado TR; Reiman RE; Price DT; Wang S; Coleman RE
J Nucl Med; 2002 Jan; 43(1):92-6. PubMed ID: 11801711
[TBL] [Abstract][Full Text] [Related]
28. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
29. Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Bretin F; Bahri MA; Bernard C; Warnock G; Aerts J; Mestdagh N; Buchanan T; Otoul C; Koestler F; Mievis F; Giacomelli F; Degueldre C; Hustinx R; Luxen A; Seret A; Plenevaux A; Salmon E
Mol Imaging Biol; 2015 Aug; 17(4):557-64. PubMed ID: 25595813
[TBL] [Abstract][Full Text] [Related]
30. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
31. Imaging of striatal dopamine D(2) receptors with a PET system for small laboratory animals in comparison with storage phosphor autoradiography: a validation study with (18)F-(N-methyl)benperidol.
Nikolaus S; Larisch R; Beu M; Vosberg H; Müller-Gärtner HW
J Nucl Med; 2001 Nov; 42(11):1691-6. PubMed ID: 11696641
[TBL] [Abstract][Full Text] [Related]
32. Dosimetric estimates for clinical positron emission tomographic scanning after injection of [18F]-6-fluorodopamine.
Goldstein DS; Chang PC; Smith CB; Herscovitch P; Austin SM; Eisenhofer G; Kopin IJ
J Nucl Med; 1991 Jan; 32(1):102-10. PubMed ID: 1988612
[TBL] [Abstract][Full Text] [Related]
33. In Vivo Brain Imaging, Biodistribution, and Radiation Dosimetry Estimation of [
Kumar JSD; Bai B; Zanderigo F; DeLorenzo C; Prabhakaran J; Parsey RV; Mann JJ
Molecules; 2018 Aug; 23(8):. PubMed ID: 30072617
[TBL] [Abstract][Full Text] [Related]
34. Biodistribution and radiation dosimetry of the dopamine D2 ligand 11C-raclopride determined from human whole-body PET.
Slifstein M; Hwang DR; Martinez D; Ekelund J; Huang Y; Hackett E; Abi-Dargham A; Laruelle M
J Nucl Med; 2006 Feb; 47(2):313-9. PubMed ID: 16455638
[TBL] [Abstract][Full Text] [Related]
35. Fluorine-18-fluoro-L-DOPA dosimetry with carbidopa pretreatment.
Brown WD; Oakes TR; DeJesus OT; Taylor MD; Roberts AD; Nickles RJ; Holden JE
J Nucl Med; 1998 Nov; 39(11):1884-91. PubMed ID: 9829576
[TBL] [Abstract][Full Text] [Related]
36. Amyloid plaque imaging agent [C-11]-6-OH-BTA-1: biodistribution and radiation dosimetry in baboon.
Parsey RV; Sokol LO; Bélanger MJ; Kumar JS; Simpson NR; Wang T; Pratap M; Van Heertum RL; John Mann J
Nucl Med Commun; 2005 Oct; 26(10):875-80. PubMed ID: 16160646
[TBL] [Abstract][Full Text] [Related]
37. Dosimetry of a D2/D3 dopamine receptor antagonist that can be used with PET or SPECT.
Mozley PD; Stubbs JB; Kim HJ; McElgin W; Chumpradit S; Kung MP; Romaniello G; Kung HF
J Nucl Med; 1995 Jul; 36(7):1322-31. PubMed ID: 7790963
[TBL] [Abstract][Full Text] [Related]
38. Radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose in adult humans.
Dowd MT; Chen CT; Wendel MJ; Faulhaber PJ; Cooper MD
J Nucl Med; 1991 Apr; 32(4):707-12. PubMed ID: 2013811
[TBL] [Abstract][Full Text] [Related]
39. Radiation dosimetry of O-(3-[18F]fluoropropyl)-L-tyrosine as oncologic PET tracer based on the mice distribution data.
Tang G; Tang X; Wang M; Luo L; Gan M
Appl Radiat Isot; 2004 Jan; 60(1):27-32. PubMed ID: 14687633
[TBL] [Abstract][Full Text] [Related]
40. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
